Nitrate and nitrite in the diet: How to assess their benefit and risk for human health

Molecular Nutrition and Food Research

Volumn 59, Issue 1, 2015, Pages 106-128

  Habermeyer, Michael ^a   Roth, Angelika ^a   Guth, Sabine ^a   Diel, Patrick ^b   Engel, Karl Heinz ^c   Epe, Bernd ^d   Fürst, Peter ^e   Heinz, Volker ^f   Humpf, Hans Ulrich ^g   Joost, Hans Georg ^h   Knorr, Dietrich ⁱ   de Kok, Theo ^j   Kulling, Sabine ^k   Lampen, Alfonso ^l   Marko, Doris ^m   Rechkemmer, Gerhard ^k   Rietjens, Ivonne ⁿ   Stadler, Richard H ^o   Vieths, Stefan ^p   Vogel, Rudi ^c   Steinberg, Pablo ^q   Eisenbrand, Gerhard ^a   more..

^a University of Koblenz Landau   (Germany)

^b GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e Chemical and Veterinary Analytical Institute Muensterland Emscher Lippe   (Germany)

^f German Institute of Food Technologies DIL   (Germany)

^g UNIVERSITY OF MÜNSTER   (Germany)

^h GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

ⁱ TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

^j MAASTRICHT UNIVERSITY   (Netherlands)

^k FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

^l FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

^m UNIVERSITY OF VIENNA   (Austria)

ⁿ WAGENINGEN UNIVERSITY   (Netherlands)

^o NESTLÉ RESEARCH CENTER   (Switzerland)

^p PAUL EHRLICH INSTITUT   (Germany)

^q UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

more..

Author keywords

Benefit risk analysis; Biomarkers; N nitroso compounds; Nitrate; Nitrite

Indexed keywords

BIOLOGICAL MARKER; NITRIC ACID DERIVATIVE; NITRIC OXIDE; NITRITE; NITROSO DERIVATIVE;

ANIMAL; BLOOD; CHEMISTRY; DIET; DISEASE MODEL; HUMAN; MEAT; METABOLISM; NEOPLASM; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; VEGETABLE;

ANIMALS; BIOLOGICAL MARKERS; DIET; DISEASE MODELS, ANIMAL; HUMANS; MEAT PRODUCTS; NEOPLASMS; NITRATES; NITRIC OXIDE; NITRITES; NITROSO COMPOUNDS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; VEGETABLES;

EID: 84921056818     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400286     Document Type: Review

References (274)

1. SKLM, in: Forschungsgemeinschaft, D. (Ed.), Lebensmittel und Gesundheit: Sammlung der Beschlüsse, Stellungnahmen und Verlautbarungen aus den Jahren 1984 bis 1996, Senatskommission zur Bewertung der gesundheitlichen Unbedenklichkeit von Lebensmitteln (SKLM), Wiley VCH, Weinheim 1998, pp. 77-86.
2. World Cancer Research Fund/American Institute for Cancer Research, Expert Report. Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. AICR, Washington, DC 2007. Available from: http://www.aicr.org/assets/docs/pdf/reports/Second_Expert_Report.pdf.
3. Weitzberg, E., Lundberg, J. O., Novel aspects of dietary nitrate and human health. Annu. Rev. Nutr. 2013, 33, 129-159.
4. Gilchrist, M., Shore, A. C., Benjamin, N., Inorganic nitrate and nitrite and control of blood pressure. Cardiovasc. Res. 2011, 89, 492-498.
5. Hord, N. G., Tang, Y. P., Bryan, N. S., Food sources of nitrates and nitrites: the physiologic context for potential health benefits. Am. J. Clin. Nutr. 2009, 90, 1-10.
6. Machha, A., Schechter, A. N., Dietary nitrite and nitrate: a review of potential mechanisms of cardiovascular benefits. Eur. J. Nutr. 2011, 50, 293-303.
7. Lidder, S., Webb, A. J., Vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate-nitrite-nitric oxide pathway. Brit. J. Clin. Pharmacol. 2013, 75, 677-696.
8. Greer, F. R., Shannon, M., Infant methemoglobinemia: the role of dietary nitrate in food and water. Pediatrics 2005, 116, 784-786.
9. European Food Safety Authority (EFSA), Opinion of the Scientific Panel on Contaminants in the Food Chain on a request from the European Commission to perform a scientific risk assessment on nitrate in vegetables. EFSA J. 2008, 689, 1-79.
10. Scientific Committee for Food (SCF), Opinion on nitrate and nitrite. Reports of the Scientific Committee for Food (SCF), Series 26, European Commission, Brussels 1992, pp. 21-28.
11. Scientific Committee for Food (SCF), Opinion on nitrate and nitrite. Reports of the Scientific Committee for Food (SCF), Series 38, European Commission, Brussels 1997.
12. FAO/WHO, Nitrate (and Potential Endogenous Formation of N-Nitroso Compounds). WHO Food Additive Series No. 50, World Health Organisation, Geneva 2003.
13. European Food Safety Authority (EFSA), Statement on nitrites in meat products. EFSA J. 2010, 8, 1538.
14. FAO/WHO, Nitrite (and Potential Endogenous Formation of N-Nitroso Compounds). WHO Food Additive Series No. 50, World Health Organisation, Geneva 2003.
15. Caulfield, J. L., Wishnok, J. S., Tannenbaum, S. R., Nitric oxide-induced deamination of cytosine and guanine in deoxynucleosides and oligonucleotides. J. Biol. Chem. 1998, 273, 12689-12695.
16. Burney, S., Caulfield, J. L., Niles, J. C., Wishnok, J. S. et al., The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat. Res. 1999, 424, 37-49.
17. Eiserich, J. P., Patel, R. P., O'Donnell, V. B., Pathophysiology of nitric oxide and related species: free radical reactions and modification of biomolecules. Mol. Aspects Med. 1998, 19, 221-357.
18. Gal, A., Tamir, S., Kennedy, L. J., Tannenbaum, S. R., Wogan, G. N., Nitrotyrosine formation, apoptosis, and oxidative damage: relationships to nitric oxide production in SJL mice bearing the RcsX tumor. Cancer Res. 1997, 57, 1823-1828.
19. d'Ischia, M., Napolitano, A., Manini, P., Panzella, L., Secondary targets of nitrite-derived reactive nitrogen species: nitrosation/nitration pathways, antioxidant defense mechanisms and toxicological implications. Chem. Res. Toxicol. 2011, 24, 2071-2092.
20. Knutson, C. G., Mangerich, A., Zeng, Y., Raczynski, A. R. et al., Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease. Proc. Natl. Acad. Sci. USA 2013, 110, 2332-2341.
21. Green, L. C., Deluzuriaga, K. R., Wagner, D. A., Rand, W. et al., Nitrate biosynthesis in man. Proc. Natl. Acad. Sci. USA 1981, 78, 7764-7768.
22. Tannenbaum, S. R., Fett, D., Young, V. R., Land, P. D. et al., Nitrite and nitrate are formed by endogenous synthesis in human intestine. Science 1978, 200, 1487-1489.
23. Weitzberg, E., Lundberg, J. O., Nonenzymatic nitric oxide production in humans. Nitric Oxide 1998, 2, 1-7.
24. Reutov, V. P., Sorokina, E. G., NO-synthase and nitrite-reductase components of nitric oxide cycle. Biochemistry (Mosc.) 1998, 63, 874-884.
25. Lundberg, J. O., Govoni, M., Inorganic nitrate is a possible source for systemic generation of nitric oxide. Free Radic. Biol. Med. 2004, 37, 395-400.
26. Zhang, Z., Naughton, D., Winyard, P. G., Benjamin, N. et al., Generation of nitric oxide by a nitrite reductase activity of xanthine oxidase: a potential pathway for nitric oxide formation in the absence of nitric oxide synthase activity. Biochem. Biophys. Res. Commun. 1998, 249, 767-772.
27. Gladwin, M. T., Cosby, K., Partovi, K., Martyr, S. et al., Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilalates the human circulation. Circulation 2003, 108, 20-21.
28. Marletta, M. A., Yoon, P. S., Iyengar, R., Leaf, C. D. et al., Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 1988, 27, 8706-8711.
29. Leaf, C. D., Wishnok, J. S., Tannenbaum, S. R., L-arginine is a precursor for nitrate biosynthesis in humans. Biochem. Biophys. Res. Commun. 1989, 163, 1032-1037.
30. Wennmalm, A., Benthin, G., Edlund, A., Jungersten, L. et al., Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ. Res. 1993, 73, 1121-1127.
31. Van den Brandt, P. A., Willett, W. C., Tannenbaum, S. R., Assessment of dietary nitrate intake by a self-administered questionnaire and by overnight urinary measurement. Int. J. Epidemiol. 1989, 18, 852-857.
32. Moncada, S., Higgs, A., The L-arginine-nitric oxide pathway. N. Engl. J. Med. 1993, 329, 2002-2012.
33. Hattori, R., Sase, K., Eizawa, H., Kosuga, K. et al., Structure and function of nitric oxide synthases. Int. J. Cardiol. 1994, 47, S71-S75.
34. Ohshima, H., Bandaletova, T. Y., Brouet, I., Bartsch, H. et al., Increased nitrosamine and nitrate biosynthesis mediated by nitric oxide synthase induced in hamsters infected with liver fluke (Opisthorchis viverrini). Carcinogenesis 1994, 15, 271-275.
35. Bartsch, H., Ohshima, H., Pignatelli, B., Calmels, S., Endogenously formed N-nitroso compounds and nitrosating agents in human cancer etiology. Pharmacogenetics 1992, 2, 272-277.
36. Schaus, R., Griess' nitrite test in diagnosis of urinary infection. J. Am. Med. Assoc. 1956, 161, 528-529.
37. Stuehr, D. J., Marletta, M. A., Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA 1985, 82, 7738-7742.
38. Hofseth, L. J., Hussain, S. P., Wogan, G. N., Harris, C. C., Nitric oxide in cancer and chemoprevention. Free Radic. Biol. Med. 2003, 34, 955-968.
39. Hussain, S. P., He, P., Subleski, J., Hofseth, L. J. et al., Nitric oxide is a key component in inflammation-accelerated tumorigenesis. Cancer Res. 2008, 68, 7130-7136.
40. Srivatanakul, P., Ohshima, H., Khlat, M., Parkin, M. et al., Opisthorchis viverrini infestation and endogenous nitrosamines as risk factors for cholangiocarcinoma in Thailand. Int. J. Cancer 1991, 48, 821-825.
41. Sripa, B., Brindley, P. J., Mulvenna, J., Laha, T. et al., The tumorigenic liver fluke Opisthorchis viverrini-multiple pathways to cancer. Trends Parasitol. 2012, 28, 395-407.
42. Jenkins-Holick, D. S., Kaul, T. L., Schistosomiasis. Urol. Nurs. 2013, 33, 163-170.
43. Mostafa, M. H., Helmi, S., Badawi, A. F., Tricker, A. R. et al., Nitrate, nitrite and volatile N-nitroso compounds in the urine of Schistosoma haematobium and Schistosoma mansoni infected patients. Carcinogenesis 1994, 15, 619-625.
44. Tricker, A. R., Mostafa, M. H., Spiegelhalder, B., Preussmann, R., Urinary nitrate, nitrite and N-nitroso compounds in bladder cancer patients with schistosomiasis (bilharzia). IARC Sci. Publ. 1991, 105, 178-181.
45. Tricker, A. R., Mostafa, M. H., Spiegelhalder, B., Preussmann, R., Urinary excretion of nitrate, nitrite and N-nitroso compounds in Schistosomiasis and bilharzia bladder cancer patients. Carcinogenesis 1989, 10, 547-552.
46. Calmels, S., Ohshima, H., Crespi, M., Leclerc, H. et al., N-nitrosamine formation by microorganisms isolated from human gastric juice and urine: biochemical studies on bacteria-catalysed nitrosation. IARC Sci. Publ. 1987, 84, 391-395.
47. Calmels, S., Ohshima, H., Rosenkranz, H., McCoy, E. et al., Biochemical studies on the catalysis of nitrosation by bacteria. Carcinogenesis 1987, 8, 1085-1088.
48. Leach, S. A., Thompson, M., Hill, M., Bacterially catalysed N-nitrosation reactions and their relative importance in the human stomach. Carcinogenesis 1987, 8, 1907-1912.
49. Tricker, A. R., Kalble, T., Preussmann, R., Increased urinary nitrosamine excretion in patients with urinary diversions. Carcinogenesis 1989, 10, 2379-2382.
50. Tricker, A. R., Stickler, D. J., Chawla, J. C., Preussmann, R., Increased urinary nitrosamine excretion in paraplegic patients. Carcinogenesis 1991, 12, 943-946.
51. Correa, P., Haenszel, W., Cuello, C., Zavala, D. et al., Gastric precancerous process in a high risk population: cross-sectional studies. Cancer Res. 1990, 50, 4731-4736.
52. Ziebarth, D., Spiegelhalder, B., Bartsch, H., N-nitrosation of medicinal drugs catalysed by bacteria from human saliva and gastro-intestinal tract, including Helicobacter pylori. Carcinogenesis 1997, 18, 383-389.
53. Akuta, T., Zaki, M. H., Yoshitake, J., Okamoto, T. et al., Nitrative stress through formation of 8-nitroguanosine: insights into microbial pathogenesis. Nitric Oxide 2006, 14, 101-108.
54. Dedon, P. C., Tannenbaum, S. R., Reactive nitrogen species in the chemical biology of inflammation. Arch. Biochem. Biophys. 2004, 423, 12-22.
55. Sawa, T., Ohshima, H., Nitrative DNA damage in inflammation and its possible role in carcinogenesis. Nitric Oxide 2006, 14, 91-100.
56. Spiegelhalder, B., Eisenbrand, G., Preussmann, R., Influence of dietary nitrate on nitrite content of human saliva: possible relevance to in vivo formation of N-nitroso compounds. Food Cosmet. Toxicol. 1976, 14, 545-548.
57. Tannenbaum, S. R., Weisman, M., Fett, D., Effect of nitrate intake on nitrite formation in human saliva. Food Cosmet. Toxicol. 1976, 14, 549-552.
58. Qin, L., Liu, X., Sun, Q., Fan, Z. et al., Sialin (SLC17A5) functions as a nitrate transporter in the plasma membrane. Proc. Natl. Acad. Sci. USA 2012, 109, 13434-13439.
59. Eisenbrand, G., Spiegelhalder, B., Preussmann, R., Nitrate and nitrite in saliva. Oncology 1980, 37, 227-231.
60. Eisenbrand, G., in: Nicolai, H. V., Eisenbrand, G., Bozler, G. (Eds.), The Significance of N-Nitrosation of Drugs, Gustav Fischer Verlag, Stuttgart, New York 1990, pp. 47-69.
61. Lundberg, J. O., Weitzberg, E., Lundberg, J. M., Alving, K., Intragastric nitric oxide production in humans: measurements in expelled air. Gut 1994, 35, 1543-1546.
62. Benjamin, N., O'Driscoll, F., Dougall, H., Duncan, C. et al., Stomach NO synthesis. Nature 1994, 368, 502.
63. Lundberg, J. O., Weitzberg, E., Cole, J. A., Benjamin, N., Nitrate, bacteria and human health. Nat. Rev. Microbiol. 2004, 2, 593-602.
64. Dykhuizen, R. S., Fraser, A., McKenzie, H., Golden, M. et al., Helicobacter pylori is killed by nitrite under acidic conditions. Gut 1998, 42, 334-337.
65. Park, A. M., Nagata, K., Sato, E. F., Tamura, T. et al., Mechanism of strong resistance of Helicobacter pylori respiration to nitric oxide. Arch. Biochem. Biophys. 2003, 411, 129-135.
66. Justino, M. C., Ecobichon, C., Fernandes, A. F., Boneca, I. G. et al., Helicobacter pylori has an unprecedented nitric oxide detoxifying system. Antioxid. Redox Signal. 2012, 17, 1190-1200.
67. Govoni, M., Jansson, E. A., Weitzberg, E., Lundberg, J. O., The increase in plasma nitrite after a dietary nitrate load is markedly attenuated by an antibacterial mouthwash. Nitric Oxide 2008, 19, 333-337.
68. Jansson, E. A., Huang, L., Malkey, R., Govoni, M. et al., A mammalian functional nitrate reductase that regulates nitrite and nitric oxide homeostasis. Nat. Chem. Biol. 2008, 4, 411-417.
69. Gladwin, M. T., Cosby, K., Partovi, K. S., Patel, R. P. et al., Novel function of human hemoglobin as a nitrite reductase regulates nitric oxide homeostasis and hypoxic vasodilation. Blood 2003, 102, 255a.
70. Gladwin, M. T., Schechter, A. N., Kim-Shapiro, D. B., Patel, R. P. et al., The emerging biology of the nitrite anion. Nat. Chem. Biol. 2005, 1, 308-314.
71. van Faassen, E. E., Bahrami, S., Feelisch, M., Hogg, N. et al., Nitrite as regulator of hypoxic signaling in mammalian physiology. Med. Res. Rev. 2009, 29, 683-741.
72. Shiva, S., Huang, Z., Grubina, R., Sun, J. H. et al., Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ. Res. 2007, 100, 654-661.
73. Cosby, K., Partovi, K. S., Crawford, J. H., Patel, R. P. et al., Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat. Med. 2003, 9, 1498-1505.
74. Nagababu, E., Ramasamy, S., Abernethy, D. R., Rifkind, J. M., Active nitric oxide produced in the red cell under hypoxic conditions by deoxyhemoglobin-mediated nitrite reduction. J. Biol. Chem. 2003, 278, 46349-46356.
75. Baliga, R. S., Milsom, A. B., Ghosh, S. M., Trinder, S. L. et al., Dietary nitrate ameliorates pulmonary hypertension cytoprotective role for endothelial nitric oxide synthase and xanthine oxidoreductase. Circulation 2012, 125, 2922-2932.
76. Millar, T. M., Stevens, C. R., Blake, D. R., Xanthine oxidase can generate nitric oxide from nitrate in ischaemia. Biochem. Soc. Trans. 1997, 25, 528S.
77. Huang, Z., Shiva, S., Kim-Shapiro, D. B., Patel, R. P. et al., Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control. J. Clin. Invest. 2005, 115, 2099-2107.
78. Moncada, S., Palmer, R. M., Higgs, E. A., Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991, 43, 109-142.
79. Rees, D. D., Palmer, R. M. J., Moncada, S., Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. USA 1989, 86, 3375-3378.
80. Ceccatelli, S., Lundberg, J. M., Fahrenkrug, J., Bredt, D. S. et al., Evidence for involvement of nitric oxide in the regulation of hypothalamic portal blood flow. Neuroscience 1992, 51, 769-772.
81. Palmer, R. M., Ferrige, A. G., Moncada, S., Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327, 524-526.
82. Radomski, M. W., Palmer, R. M., Moncada, S., Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987, 2, 1057-1058.
83. Radomski, M. W., Palmer, R. M., Moncada, S., The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Brit. J. Pharmacol. 1987, 92, 639-646.
84. Rand, M. J., Nitrergic transmission: nitric oxide as a mediator of non-adrenergic, non-cholinergic neuro-effector transmission. Clin. Exp. Pharmacol. Physiol. 1992, 19, 147-169.
85. Bredt, D. S., Snyder, S. H., Nitric oxide, a novel neuronal messenger. Neuron 1992, 8, 3-11.
86. Garthwaite, J., Boulton, C. L., Nitric oxide signaling in the central nervous system. Annu. Rev. Physiol. 1995, 57, 683-706.
87. Larsen, F. J., Schiffer, T. A., Weitzberg, E., Lundberg, J. O., Regulation of mitochondrial function and energetics by reactive nitrogen monoxides. Free Radic. Biol. Med. 2012, 53, 1919-1928.
88. Ceccatelli, S., Hulting, A. L., Zhang, X., Gustafsson, L. et al., Nitric oxide synthase in the rat anterior pituitary gland and the role of nitric oxide in regulation of luteinizing hormone secretion. Proc. Natl. Acad. Sci. USA 1993, 90, 11292-11296.
89. Langrehr, J. M., Hoffman, R. A., Lancaster, J. R., Simmons, R. L., Nitric oxide-a new endogenous immunomodulator. Transplantation 1993, 55, 1205-1212.
90. Wei, X. Q., Charles, I. G., Smith, A., Ure, J. et al., Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995, 375, 408-411.
91. Green, S. J., Scheller, L. F., Marletta, M. A., Seguin, M. C. et al., Nitric oxide: cytokine-regulation of nitric oxide in host resistance to intracellular pathogens. Immunol. Lett. 1994, 43, 87-94.
92. Carnovale, C. E., Ronco, M. T., Role of nitric oxide in liver regeneration. Ann. Hepatol. 2012, 11, 636-647.
93. Liu, Y., Feng, Q., NOing the heart: role of nitric oxide synthase-3 in heart development. Differentiation 2012, 84, 54-61.
94. Heinrich, U. R., Helling, K., Nitric oxide-a versatile key player in cochlear function and hearing disorders. Nitric Oxide 2012, 27, 106-116.
95. Steinberg, A., Nilsson Remahl, A. I., Role of nitric oxide in cluster headache. Curr. Pain Headache Rep. 2012, 16, 185-190.
96. Grasemann, H., Ratjen, F., Nitric oxide and L-arginine deficiency in cystic fibrosis. Curr. Pharm. Des. 2012, 18, 726-736.
97. Kroncke, K. D., Fehsel, K., Suschek, C., Kolb-Bachofen, V., Inducible nitric oxide synthase-derived nitric oxide in gene regulation, cell death and cell survival. Int. Immunopharmacol. 2001, 1, 1407-1420.
98. Messmer, U. K., Brune, B., Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways. Biochem. J. 1996, 319, 299-305.
99. Burke, A. J., Sullivan, F. J., Giles, F. J., Glynn, S. A., The yin and yang of nitric oxide in cancer progression. Carcinogenesis 2013, 34, 503-512.
100. Mocellin, S., Nitric oxide: cancer target or anticancer agent? Curr. Cancer Drug Targets 2009, 9, 214-236.
101. Xu, W., Liu, L. Z., Loizidou, M., Ahmed, M. et al., The role of nitric oxide in cancer. Cell Res. 2002, 12, 311-320.
102. Morcos, E., Carlsson, S., Weitzberg, E., Wiklund, N. P. et al., Inhibition of cancer cell replication by inorganic nitrite. Nutr. Cancer 2010, 62, 501-504.
103. Dejam, A., Hunter, C. J., Gladwin, M. T., Effects of dietary nitrate on blood pressure. N. Engl. J. Med. 2007, 356, 1590-1590.
104. Kapil, V., Milsom, A. B., Okorie, M., Maleki-Toyserkani, S. et al., Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO. Hypertension 2010, 56, 274-281.
105. Larsen, F. J., Ekblom, B., Sahlin, K., Lundberg, J. O. et al., Effects of dietary nitrate on blood pressure in healthy volunteers. N. Engl. J. Med. 2006, 355, 2792-2793.
106. Gladwin, M. T., Shelhamer, J. H., Schechter, A. N., Pease-Fye, M. E. et al., Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. Proc. Natl. Acad. Sci. USA 2000, 97, 11482-11487.
107. Lundberg, J. O., Weitzberg, E., NO generation from nitrite and its role in vascular control. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 915-922.
108. Maher, A. R., Thomas, P., Anderson, S., Abozguia, K. et al., Intra-arterial nitrite causes an enduring vasodilation in man. J. Am. Coll. Cardiol. 2008, 51, A284.
109. Velmurugan, S., Pearl, V., Davies, S., Bahra, M. et al., Inorganic nitrate supplementation attenuates platelet reactivity in healthy male volunteers. Nitric Oxide 2012, 27, S27-S28.
110. Jung, K. H., Chu, K., Ko, S. Y., Lee, S. T. et al., Early intravenous infusion of sodium nitrite protects brain against in vivo ischemia-reperfusion injury. Stroke 2006, 37, 2744-2750.
111. Webb, A., Bond, R., McLean, P., Uppal, R. et al., Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. Proc. Natl. Acad. Sci. USA 2004, 101, 13683-13688.
112. Duranski, M. R., Greer, J. J., Dejam, A., Jaganmohan, S. et al., Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J. Clin. Invest. 2005, 115, 1232-1240.
113. Tripatara, P., Patel, N. S. A., Webb, A., Rathod, K. et al., Nitrite-derived nitric oxide protects the rat kidney against ischemia/reperfusion injury in vivo: role for xanthine oxidoreductase. J. Am. Soc. Nephrol. 2007, 18, 570-580.
114. Hendgen-Cotta, U. B., Luedike, P., Totzeck, M., Kropp, M. et al., Dietary nitrate supplementation improves revascularization in chronic ischemia. Circulation 2012, 126, 1983-1992.
115. Dejam, A., Hunter, C. J., Tremonti, C., Pluta, R. M. et al., Nitrite infusion in humans and nonhuman primates: endocrine effects, pharmacokinetics, and tolerance formation. Circulation 2007, 116, 1821-1831.
116. Heiss, C., Meyer, C., Totzeck, M., Hendgen-Cotta, U. B. et al., Dietary inorganic nitrate mobilizes circulating angiogenic cells. Free Radic. Biol. Med. 2012, 52, 1767-1772.
117. Webb, A. J., Patel, N., Loukogeorgakis, S., Okorie, M. et al., Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension 2008, 51, 784-790.
118. Aboud, Z., Misra, S., Warner, T., Miall, P. et al., The enterosalivary bioconversion of nitrate to nitrite underlies the blood pressure (BP) lowering and anti-platelet effects of a dietary nitrate load. Brit. J. Clin. Pharmacol. 2008, 65, 999.
119. Richardson, G., Hicks, S. L., O'Byrne, S., Frost, M. T. et al., The ingestion of inorganic nitrate increases gastric S-nitrosothiol levels and inhibits platelet function in humans. Nitric Oxide 2002, 7, 24-29.
120. Carlstrom, M., Persson, A. E., Larsson, E., Hezel, M. et al., Dietary nitrate attenuates oxidative stress, prevents cardiac and renal injuries, and reduces blood pressure in salt-induced hypertension. Cardiovasc. Res. 2011, 89, 574-585.
121. Bjorne, H. H., Petersson, J., Phillipson, M., Weitzberg, E. et al., Nitrite in saliva increases gastric mucosal blood flow and mucus thickness. J. Clin. Invest. 2004, 113, 106-114.
122. Petersson, J., Phillipson, M., Jansson, E. A., Patzak, A. et al., Dietary nitrate increases gastric mucosal blood flow and mucosal defense. Am. J. Physiol. 2007, 292, G718-G724.
123. Carlstrom, M., Larsen, F. J., Nystrom, T., Hezel, M. et al., Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice. Proc. Natl. Acad. Sci. USA 2010, 107, 17716-17720.
124. Fernandez, M. L., Ruiz, R., Gonzalez, M. A., Ramirez-Lorca, R. et al., Association of NOS3 gene with metabolic syndrome in hypertensive patients. Thromb. Haemost. 2004, 92, 413-418.
125. Huang, P. L., eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol. Metab. 2009, 20, 295-302.
126. Moncada, S., Palmer, R. M., Higgs, E. A., The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension 1988, 12, 365-372.
127. Modin, A., Bjorne, H., Herulf, M., Alving, K. et al., Nitrite-derived nitric oxide: a possible mediator of 'acidic-metabolic' vasodilation. Acta Physiol. Scand. 2001, 171, 9-16.
128. Rodriguez, J., Maloney, R. E., Rassaf, T., Bryan, N. S. et al., Chemical nature of nitric oxide storage forms in rat vascular tissue. Proc. Natl. Acad. Sci. USA 2003, 100, 336-341.
129. Webb, A. J., Milsom, A. B., Rathod, K. S., Chu, W. L. et al., Mechanisms underlying erythrocyte and endothelial nitrite reduction to nitric oxide in hypoxia: role for xanthine oxidoreductase and endothelial nitric oxide synthase. Circ. Res. 2008, 103, 957-964.
130. Petersson, J., Carlstrom, M., Schreiber, O., Phillipson, M. et al., Gastroprotective and blood pressure lowering effects of dietary nitrate are abolished by an antiseptic mouthwash. Free Radic. Biol. Med. 2009, 46, 1068-1075.
131. Kapil, V., Haydar, S. M., Pearl, V., Lundberg, J. O. et al., Physiological role for nitrate-reducing oral bacteria in blood pressure control. Free Radic. Biol. Med. 2013, 55, 93-100.
132. Zweier, J. L., Wang, P., Kuppusamy, P., Direct measurement of nitric oxide generation in the ischemic heart using electron paramagnetic resonance spectroscopy. J. Biol. Chem. 1995, 270, 304-307.
133. Zweier, J. L., Wang, P., Samouilov, A., Kuppusamy, P., Enzyme-independent formation of nitric oxide in biological tissues. Nat. Med. 1995, 1, 804-809.
134. Duranski, M. R., Greer, J. J. M., Dejam, A., Jaganmohan, S. et al., Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J. Clin. Invest. 2005, 115, 1232-1240.
135. Kapil, V., Okorie, M., Akram, F., Rehman, F. et al., Oral inorganic nitrate lowers blood pressure and protects against endothelial ischaemia-reperfusion injury in humans. Nitric Oxide 2009, 20, S37.
136. Okorie, M., Akram, F., Loukogeorgakis, S., Webb, A. et al., Oral inorganic nitrate protects against endothelial ischaemia-reperfusion injury in humans. Basic Clin. Pharmacol. 2009, 105, 26.
137. Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E. et al., Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA 1987, 84, 9265-9269.
138. Khan, M. T., Furchgott, R. F., Similarities of behavior of nitric oxide (NO) and endothelium-derived relaxing factor in a perfusion cascade bioassay system. Fed. Proc. 1987, 46, 385A.
139. Srihirun, S., Sriwantana, T., Unchern, S., Kittikool, D. et al., Platelet inhibition by nitrite is dependent on erythrocytes and deoxygenation. PLoS One 2012, 7, e30380.
140. Joshipura, K. J., Ascherio, A., Manson, J. E., Stampfer, M. J. et al., Fruit and vegetable intake in relation to risk of ischemic stroke. J. Am. Med. Assoc. 1999, 282, 1233-1239.
141. Joshipura, K. J., Hu, F. B., Manson, J. E., Stampfer, M. J. et al., The effect of fruit and vegetable intake on risk for coronary heart disease. Ann. Intern. Med. 2001, 134, 1106-1114.
142. Hung, H. C., Joshipura, K. J., Jiang, R., Hu, F. B. et al., Fruit and vegetable intake and risk of major chronic disease. J. Natl. Cancer Inst. 2004, 96, 1577-1584.
143. Lundberg, J. O., Carlstrom, M., Larsen, F. J., Weitzberg, E., Roles of dietary inorganic nitrate in cardiovascular health and disease. Cardiovasc. Res. 2011, 89, 525-532.
144. Carter, P., Gray, L. J., Troughton, J., Khunti, K. et al., Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. Brit. Med. J. 2010, 341, c4229.
145. Webb, A. J., Patel, N., Loukogeorgakis, S., Okorie, M. et al., Acute blood pressure (BP) lowering and vasoprotective effects of beetroot juice: relationship to nitrite derived from dietary nitrate. J. Hum. Hypertens. 2007, 21, 834-835.
146. Kapil, V., Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO (vol 56, 274, 2010). Hypertension 2010, 56, e37-e39.
147. Siervo, M., Lara, J., Ogbonmwan, I., Mathers, J. C., Inorganic nitrate and beetroot juice supplementation reduces blood pressure in adults: a systematic review and meta-analysis. J. Nutr. 2013, 143, 818-826.
148. Sobko, T., Marcus, C., Govoni, M., Kamiya, S., Dietary nitrate in Japanese traditional foods lowers diastolic blood pressure in healthy volunteers. Nitric Oxide 2010, 22, 136-140.
149. Bailey, S. J., Fulford, J., Vanhatalo, A., Winyard, P. G. et al., Dietary nitrate supplementation enhances muscle contractile efficiency during knee-extensor exercise in humans. J. Appl. Physiol. 2010, 109, 135-148.
150. 2 cost of low-intensity exercise and enhances tolerance to high-intensity exercise in humans. J. Appl. Physiol. 2009, 107, 1144-1155.
151. 2 cost of walking and running: a placebo-controlled study. J. Appl. Physiol. 2011, 110, 591-600.
152. Vanhatalo, A., Bailey, S. J., Blackwell, J. R., DiMenna, F. J. et al., Acute and chronic effects of dietary nitrate supplementation on blood pressure and the physiological responses to moderate-intensity and incremental exercise. Am. J. Physiol. 2010, 299, R1121-R1131.
153. Bailey, S. J., Fulford, J., Vanhatalo, A., Winyard, P. G. et al., Dietary nitrate supplementation enhances muscle contractile efficiency during knee-extensor exercise in humans. J. Appl. Physiol. 2010, 109, 135-148.
154. Larsen, F. J., Schiffer, T. A., Borniquel, S., Sahlin, K. et al., Dietary inorganic nitrate improves mitochondrial efficiency in humans. Cell Metab. 2011, 13, 149-159.
155. Kenjale, A. A., Ham, K. L., Stabler, T., Robbins, J. L. et al., Dietary nitrate supplementation enhances exercise performance in peripheral arterial disease. J. Appl. Physiol. 2011, 110, 1582-1591.
156. Collins, R., Peto, R., MacMahon, S., Hebert, P. et al., Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990, 335, 827-838.
157. Lv, J., Neal, B., Ehteshami, P., Ninomiya, T. et al., Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis. PLoS Med. 2012, 9, e1001293.
158. Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M. et al., Effects of torcetrapib in patients at high risk for coronary events. N. Engl. J. Med. 2007, 357, 2109-2122.
159. Ivankovic, S., Teratogenic and carcinogenic effects of some chemicals during perinatal life in rats, Syrian golden hamsters, and minipigs. Natl. Cancer Inst. Monog. 1979, 51, 103-115.
160. Platzek, T., Bochert, G., Rahm, U., Embryotoxicity induced by alkylating agents. Teratogenicity of acetoxymethyl-methylnitrosamine: dose-response relationship, application route dependency and phase specificity. Arch. Toxicol. 1983, 52, 45-69.
161. Nagao, T., Morita, Y., Ishizuka, Y., Wada, A. et al., Induction of fetal malformations after treatment of mouse embryos with methylnitrosourea at the preimplantation stages. Teratog. Carcinog. Mutagen. 1991, 11, 1-10.
162. Lijinsky, W., Chemistry and Biology of N-Nitroso Compounds. University Press, Cambridge 1992.
163. Voss, C., Herrmann, I., Hartmann, K., Zuhlke, H. et al., Diabetogenic effects of N-nitrosomethylurea in rats. Exp. Clin. Endocrinol. 1988, 92, 25-31.
164. Brender, J. D., Werler, M. M., Kelley, K. E., Vuong, A. M. et al., Nitrosatable drug exposure during early pregnancy and neural tube defects in offspring: National Birth Defects Prevention Study. Am. J. Epidemiol. 2011, 174, 1286-1295.
165. Brender, J. D., Werler, M. M., Shinde, M. U., Vuong, A. M. et al., Nitrosatable drug exposure during the first trimester of pregnancy and selected congenital malformations. Birth Defects Res. A Clin. Mol. Teratol. 2012, 94, 701-713.
166. Huber, J., Zheng, Q., Sharkey, J., Brender, J. et al., Dietary nitrates, nitrites and nitrosatable compounds and neural tube defects, oral clefts and limb deficiencies. Am. J. Epidemiol. 2011, 173, S297-S297.
167. Huber, J. C., Jr., Brender, J. D., Zheng, Q., Sharkey, J. R. et al., Maternal dietary intake of nitrates, nitrites and nitrosamines and selected birth defects in offspring: a case-control study. Nutr. J. 2013, 12, 34.
168. Shinde, M. U., Vuong, A. M., Brender, J. D., Werler, M. M. et al., Prenatal exposure to nitrosatable drugs, vitamin C, and risk of selected birth defects. Birth Defects Res. A Clin. Mol. Teratol. 2013, 97, 515-531.
169. Brender, J. D., Olive, J. M., Felkner, M., Suarez, L. et al., Dietary nitrites and nitrates, nitrosatable drugs, and neural tube defects. Epidemiology 2004, 15, 330-336.
170. Li, Z. W., Zhang, L., Ye, R. W., Liu, J. M. et al., Maternal periconceptional consumption of pickled vegetables and risk of neural tube defects in offspring. Chin. Med. J. 2011, 124, 1629-1633.
171. McKean-Cowdin, R., Pogoda, J. M., Lijinsky, W., Holly, E. A. et al., Maternal prenatal exposure to nitrosatable drugs and childhood brain tumours. Int. J. Epidemiol. 2003, 32, 211-217.
172. Croen, L. A., Todoroff, K., Shaw, G. M., Maternal exposure to nitrate from drinking water and diet and risk for neural tube defects. Am. J. Epidemiol. 2001, 153, 325-331.
173. Sander, J., Burkle, G., Induction of malignant tumors in rats by simultaneous feeding of nitrite and secondary amines. Z. Krebsforsch. 1969, 73, 54-66.
174. Ohshima, H., Bartsch, H., Quantitative estimation of endogenous nitrosation in humans by monitoring N-nitrosoproline excreted in the urine. Cancer Res. 1981, 41, 3658-3662.
175. Ohshima, H., Bereziat, J. C., Bartsch, H., Measurement of endogenous N-nitrosation in rats and humans by monitoring urinary and faecal excretion of N-nitrosamino acids. IARC Sci. Publ. 1982, 41, 397-411.
176. Janzowski, C., Hemm, I., Eisenbrand, G., in: Wichmann, H.-E., Schlipköter, H. W., Fülgraff, G. (Eds.), Handbuch der Umweltmedizin, ecomed Verlagsgesellschaft, Landsberg 2000.
177. World Cancer Research Fund/American Institute for Cancer Research. Systematic Literature Review Continuous Update Project Report: The Associations between Food, Nutrition and Physical Activity and the Risk of Colorectal Cancer, 2010. Available from: http://www.wcrf.org/sites/default/files/SLRorectal_cancer_2010.pdf.
178. Ridd, J. H., Nitrosation, diazotisation, and deamination. Q. Rev. Chem. Soc. 1961, 15, 418-441.
179. Mirvish, S. S., Formation of N-nitroso compounds: Chemistry, kinetics, and in vivo occurrence. Toxicol. Appl. Pharm. 1975, 31, 325-351.
180. Mirvish, S. S., Kinetics of dimethylamine nitrosation in relation to nitrosamine carcinogenesis. J. Natl. Cancer Inst. 1970, 44, 633-639.
181. Keefer, L. K., Roller, P. P., N-nitrosation by nitrite ion in neutral and basic medium. Science 1973, 181, 1245-1247.
182. Loeppky, R. N., Bao, Y. T., Bae, J. Y., Yu, L. et al., in: Loeppky, R. N., Michejda, C. J. (Eds.), Nitrosamines and Related N-Nitroso Compounds: Chemistry and Biochemistry, American Chemical Society, Washington, DC 1994, pp. 52-65.
183. Abraham, S. K., Khandelwal, N., Ascorbic acid and dietary polyphenol combinations protect against genotoxic damage induced in mice by endogenous nitrosation. Mutat. Res. 2013, 757, 167-172.
184. Khandelwal, N., Abraham, S. K., Intake of anthocyanidins pelargonidin and cyanidin reduces genotoxic stress in mice induced by diepoxybutane, urethane and endogenous nitrosation. Environ. Toxicol. Pharmacol. 2014, 37, 837-843.
185. Conforti, F., Menichini, F., Phenolic compounds from plants as nitric oxide production inhibitors. Curr. Med. Chem. 2011, 18, 1137-1145.
186. Bellander, T., in: Nicolai, H. V., Eisenbrand, G., Bozler, G. (Eds.), The Significance of N-Nitrosation of Drugs, Gustav Fischer Verlag, Stuttgart, New York 1990, pp. 213-233.
187. Habermeyer, M., Eisenbrand, G., in: Stadler, S., Lineback, D. (Eds.), Process-Induced Food Toxicants and Health Risks, John Wiley & Sons, Hoboken, New Jersey 2008.
188. Tricker, A. R., Kubacki, S. J., Review of the occurrence and formation of nonvolatile N-nitroso compounds in foods. Food Addit. Contam. 1992, 9, 39-69.
189. EU Scientific Committee on Consumer Safety (SCCS), Opinion on Nitrosamines and Secondary Amines in Cosmetic Products (SCCS/1458/11), 2012. Available from: http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_072.pdf.
190. EU Scientific Committee on Consumer Safety (SCCS), Opinion on NDELA in Cosmetic Products and Nitrosamines in Balloons (SCCS/1486/12), 2012. Available from: http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_100.pdf.
191. Lijinsky, W., in: Nicolai, H. V., Eisenbrand, G., Bozler, G. (Eds.), The Significance of N-Nitrosation of Drugs, Gustav Fischer Verlag, Stuttgart, New York 1990, pp. 93-107.
192. Vermeer, I. T. M., Pachen, D. M. F. A., Dallinga, J. W., Kleinjans, J. C. S. et al., Volatile N-nitrosamine formation after intake of nitrate at the ADI level in combination with an amine-rich diet. Environ. Health Perspect. 1998, 106, 459-463.
193. Kuhnle, G. G. C., Story, G. W., Reda, T., Mani, A. R. et al., Diet-induced endogenous formation of nitroso compounds in the GI tract. Free Radic. Biol. Med. 2007, 43, 1040-1047.
194. Tricker, A. R., Kumar, R., Siddiqi, M., Khuroo, M. S. et al., Endogenous formation of N-nitrosamines from piperazine and their urinary excretion following antihelminthic treatment with piperazine citrate. Carcinogenesis 1991, 12, 1595-1599.
195. Lijinsky, W., Taylor, H. W., Snyder, C., Nettesheim, P., Malignant tumors of liver and lung in rats fed aminopyrine or heptamethyleneimine together with nitrite. Nature 1973, 244, 176-177.
196. Spiegelhalder, B., in: Nicolai, H. V., Eisenbrand, G., Bozler, G. (Eds.), The Significance of N-Nitrosation of Drugs, Gustav Fischer Verlag, Stuttgart, New York 1990, pp. 199-212.
197. Spiegelhalder, B., Preussmann, R., In vivo nitrosation of amidopyrine in humans: use of "ethanol effect" for biological monitoring of N-nitrosodimethylamine in urine. Carcinogenesis 1985, 6, 545-548.
198. Adam, B., Schlag, P., Friedl, P., Preussmann, R. et al., Proline is not useful as a chemical probe to measure nitrosation in the gastrointestinal tract of patients with gastric disorders characterised by anacidic conditions. Gut 1989, 30, 1068-1075.
199. Carmella, S. G., Borukhova, A., Desai, D., Hecht, S. S., Evidence for endogenous formation of tobacco-specific nitrosamines in rats treated with tobacco alkaloids and sodium nitrite. Carcinogenesis 1997, 18, 587-592.
200. Hecht, S. S., Chen, C.-H. B., Ornaf, R. M., Jacobs, E. et al., Chemical studies on tobacco smoke. 52. Reaction of nicotine and sodium nitrite: formation of nitrosamines and fragmentation of the pyrrolidine ring. J. Org. Chem. 1978, 43, 72-76.
201. Mirvish, S. S., Sams, J., Hecht, S. S., Kinetics of nornicotine and anabasine nitrosation in relation to N'-nitrosonornicotine occurrence in tobacco and to tobacco-induced cancer. J. Natl. Cancer Inst. 1977, 59, 1211-1213.
202. Stepanov, I., Carmella, S. G., Briggs, A., Hertsgaard, L. et al., Presence of the carcinogen N'-nitrosonornicotine in the urine of some users of oral nicotine replacement therapy products. Cancer Res. 2009, 69, 8236-8240.
203. Stepanov, I., Carmella, S. G., Han, S., Pinto, A. et al., Evidence for endogenous formation of N'-nitrosonornicotine in some long-term nicotine patch users. Nicotine Tob. Res. 2009, 11, 99-105.
204. Stepanov, I., Sebero, E., Wang, R., Gao, Y. T. et al., Tobacco-specific N-nitrosamine exposures and cancer risk in the Shanghai cohort study: remarkable coherence with rat tumor sites. Int. J. Cancer 2014, 134, 2278-2283.
205. Yuan, J. M., Knezevich, A. D., Wang, R., Gao, Y. T. et al., Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers. Carcinogenesis 2011, 32, 1366-1371.
206. Hecht, S. S., Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol. 1998, 11, 559-603.
207. International Agency for Research on Cancer (IARC), Monographs on the Evaluation of the Carcinogenic Risks to Humans, Vol. 89, Smokeless Tobacco and Some Tobacco-specific N-Nitrosamines, World Health Organization, Lyon, France 2007.
208. Puju, S., Shuker, D. E. G., Bishop, W. W., Falchuk, K. R. et al., Mutagenicity of N-nitroso bile acid conjugates in Salmonella typhimurium and diploid human lymphoblasts. Cancer Res. 1982, 42, 2601-2604.
209. Busby, W. F., Shuker, D. E. G., Charnley, G., Newberne, P. M. et al., Carcinogenicity in rats of the nitrosated bile acid conjugates N-nitrosoglycocholic acid and N-nitrosotaurocholic acid. Cancer Res. 1985, 45, 1367-1371.
210. Shuker, D. E. G., Margison, G. P., Nitrosated glycine derivatives as a potential source of O6-methylguanine in DNA. Cancer Res. 1997, 57, 366-369.
211. 6-methylguanine-DNA methyltransferase. Nucleic Acids Res. 2013, 41, 3047-3055.
212. 6-methyl-2'-deoxyguanosine DNA adducts: relevance for gastrointestinal cancer. Carcinogenesis 2007, 28, 356-362.
213. 6-(carboxymethyl)-2'-deoxyguanosine: A DNA adduct formed by nitrosated glycine derivatives. Chem. Res. Toxicol. 1997, 10, 652-659.
214. 6-carboxymethyl-2'-deoxyguanosine in DNA following reaction of nitric oxide with glycine and in human blood DNA using a quantitative immunoslot blot assay. Chem. Res. Toxicol. 2004, 17, 294-300.
215. 6-carboxymethyl guanine: implications for colorectal cancer. Cancer Res. 2006, 66, 1859-1865.
216. 6-carboxymethylguanine DNA adducts in intestinal cell lines. J. Chromatogr. A 2012, 1257, 25-33.
217. Bulay, O., Mirvish, S. S., Garcia, H., Pelfrene, A. F. et al., Carcinogenicity test of 6 nitrosamides and a nitrosocyanamide administered orally to rats. J. Natl. Cancer Inst. 1979, 62, 1523-1528.
218. Cheng, G., Wang, M., Villalta, P. W., Hecht, S. S., Detection of 7-(2'-carboxyethyl)guanine but not 7-carboxymethylguanine in human liver DNA. Chem. Res. Toxicol. 2010, 23, 1089-1096.
219. Krul, C. A., Zeilmaker, M. J., Schothorst, R. C., Havenaar, R., Intragastric formation and modulation of N-nitrosodimethylamine in a dynamic in vitro gastrointestinal model under human physiological conditions. Food Chem. Toxicol. 2004, 42, 51-63.
220. Zeilmaker, M. J., Bakker, M. I., Schothorst, R., Slob, W., Risk assessment of N-nitrosodimethylamine formed endogenously after fish-with-vegetable meals. Toxicol. Sci. 2010, 116, 323-335.
221. Pfundstein, B., Tricker, A. R., Theobald, E., Spiegelhalder, B. et al., Mean daily intake of primary and secondary amines from foods and beverages in West Germany in 1989-1990. Food Chem. Toxicol. 1991, 29, 733-739.
222. Engemann, A., Focke, C., Humpf, H. U., Intestinal formation of N-nitroso compounds in the pig cecum model. J. Agric. Food Chem. 2013, 61, 998-1005.
223. Magee, P. N., Barnes, J. M., The production of malignant primary hepatic tumours in the rat by feeding dimethylnitrosamine. Brit. J. Cancer 1956, 10, 114-122.
224. Schmahl, D., Preussmann, R., Hamperl, H., Leberkrebs-erzeugende Wirkung von Diäthylnitrosamin nach oraler Gabe bei Ratten. Naturwissenschaften 1960, 47, 89.
225. Druckrey, H., Preussmann, R., Ivankovic, S., Schmahl, D., [Organotropic carcinogenic effects of 65 various N-nitroso- compounds on BD rats]. Z. Krebsforsch. 1967, 69, 103-201.
226. Berger, M. R., Schmahl, D., Edler, L., Implications of the carcinogenic hazard of low doses of three hepatocarcinogenic N-nitrosamines. Jpn. J. Cancer Res. 1990, 81, 598-606.
227. Berger, M. R., Schmahl, D., Zerban, H., Combination experiments with very low doses of three genotoxic N-nitrosamines with similar organotropic carcinogenicity in rats. Carcinogenesis 1987, 8, 1635-1643.
228. Peto, R., Gray, R., Brantom, P., Grasso, P., Dose and time relationships for tumor induction in the liver and esophagus of 4080 inbred rats by chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine. Cancer Res. 1991, 51, 6452-6469.
229. Peto, R., Gray, R., Brantom, P., Grasso, P., Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: a detailed dose-response study. Cancer Res. 1991, 51, 6415-6451.
230. Hecht, S. S., Trushin, N., Castonguay, A., Rivenson, A., Comparative tumorigenicity and DNA methylation in F344 rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-nitrosodimethylamine. Cancer Res. 1986, 46, 498-502.
231. Preussmann, R., in: Nicolai, H. V., Eisenbrand, G., Bozler, G. (Eds.), The Significance of N-Nitrosation of Drugs, Gustav Fischer Verlag, Stuttgart, New York 1990, pp. 3-18.
232. Gombar, C. T., Harrington, G. W., Pylypiw, H. M., Jr., Anderson, L. M. et al., Interspecies scaling of the pharmacokinetics of N-nitrosodimethylamine. Cancer Res. 1990, 50, 4366-4370.
233. Gombar, C. T., Harrington, G. W., Pylypiw, H. M., Jr., Bevill, R. F. et al., Pharmacokinetics of N-nitrosodimethylamine in swine. Carcinogenesis 1988, 9, 1351-1354.
234. Gombar, C. T., Pylypiw, H. M., Jr., Harrington, G. W., Pharmacokinetics of N-nitrosodimethylamine in beagles. Cancer Res. 1987, 47, 343-347.
235. Mico, B. A., Swagzdis, J. E., Hu, H. S., Keefer, L. K. et al., Low-dose in vivo pharmacokinetic and deuterium isotope effect studies of N-nitrosodimethylamine in rats. Cancer Res. 1985, 45, 6280-6285.
236. Streeter, A. J., Nims, R. W., Anderson, L. M., Heur, Y. H. et al., Single-dose toxicokinetics of N-nitrosomethylethylamine and N-nitrosomethyl (2, 2, 2-trideuterioethyl)amine in the rat. Arch. Toxicol. 1990, 64, 109-115.
237. Lijinsky, W., Structure-activity relations in carcinogenesis by N-nitroso compounds. Cancer Metastasis Rev. 1987, 6, 301-356.
238. O'Brien, J., Renwick, A. G., Constable, A., Dybing, E. et al., Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal. Food Chem. Toxicol. 2006, 44, 1613-1635.
239. Benford, D., Bolger, P. M., Carthew, P., Coulet, M. et al., Application of the margin of exposure (MOE) approach to substances in food that are genotoxic and carcinogenic. Food Chem. Toxicol. 2010, 48(Suppl 1), S2-S24.
240. European Food Safety Authority (EFSA), Opinion of the Scientific Committee on a request from EFSA related to a harmonised approach for risk assessment of substances which are both genotoxic and carcinogenic. EFSA J. 2005, 3, 31.
241. Maekawa, A., Ogiu, T., Onodera, H., Furuta, K. et al., Carcinogenicity studies of sodium nitrite and sodium nitrate in F-344 rats. Food Chem. Toxicol. 1982, 20, 25-33.
242. International Agency for Research on Cancer (IARC), Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 94, Ingested Nitrate and Nitrite, and Cyanobacterial Peptide Toxins, World Health Organization, Lyon, France 2010.
243. 1 mice, National Institutes of Health, 2001. Available from: http://ntp.niehs.nih.gov/ntp/htdocs/lt_rpts/tr495.pdf.
244. Hebels, D. G., Brauers, K. J., van Herwijnen, M. H., Georgiadis, P. A. et al., Time-series analysis of gene expression profiles induced by nitrosamides and nitrosamines elucidates modes of action underlying their genotoxicity in human colon cells. Toxicol. Lett. 2011, 207, 232-241.
245. Hebels, D. G., Jennen, D. G., van Herwijnen, M. H., Moonen, E. J. et al., Whole-genome gene expression modifications associated with nitrosamine exposure and micronucleus frequency in human blood cells. Mutagenesis 2011, 26, 753-761.
246. Hebels, D. G., Sveje, K. M., de Kok, M. C., van Herwijnen, M. H. et al., N-nitroso compound exposure-associated transcriptomic profiles are indicative of an increased risk for colorectal cancer. Cancer Lett. 2011, 309, 1-10.
247. Pignatelli, B., Chen, C.-S., Thuillier, P., Bartsch, H., in: Nicolai, H. V., Eisenbrand, G., Bozler, G. (Eds.), The Significance of N-Nitrosation of Drugs, Gustav Fischer Verlag, Stuttgart, New York 1990, pp. 123-141.
248. Hebels, D. G., Sveje, K. M., de Kok, M. C., van Herwijnen, M. H. et al., Red meat intake-induced increases in fecal water genotoxicity correlate with pro-carcinogenic gene expression changes in the human colon. Food Chem. Toxicol. 2012, 50, 95-103.
249. Hughes, R., Cross, A. J., Pollock, J. R. A., Bingham, S., Dose-dependent effect of dietary meat on endogenous colonic N-nitrosation. Carcinogenesis 2001, 22, 199-202.
250. Cross, A. J., Pollock, J. R., Bingham, S. A., Haem, not protein or inorganic iron, is responsible for endogenous intestinal N-nitrosation arising from red meat. Cancer Res. 2003, 63, 2358-2360.
251. Bastide, N. M., Pierre, F. H. F., Corpet, D. E., Heme iron from meat and risk of colorectal cancer: a meta-analysis and a review of the mechanisms involved. Cancer Prev. Res. 2011, 4, 177-184.
252. Bonnett, R., Charalambides, A. A., Martin, R. A., Sales, K. D. et al., Reactions of nitrous acid and nitric oxide with porphyrins and haems. Nitrosylhaems as nitrosating agents. J. Chem. Soc. Chem. Comm. 1975, 21, 884-885.
253. Butler, A. R., Rhodes, P., Chemistry, analysis, and biological roles of S-nitrosothiols. Anal. Biochem. 1997, 249, 1-9.
254. Gay, L. J., Mitrou, P. N., Keen, J., Bowman, R. et al., Dietary, lifestyle and clinicopathological factors associated with APC mutations and promoter methylation in colorectal cancers from the EPIC-Norfolk study. J. Pathol. 2012, 228, 405-415.
255. Oostindjer, M., Alexander, J., Amdam, G. V., Andersen, G. et al., The role of red and processed meat in colorectal cancer development. Meat Sci. 2014, 97, 583-596.
256. Sandhu, M. S., White, I. R., McPherson, K., Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-analytical approach. Cancer Epidemiol. Biomarkers Prev. 2001, 10, 439-446.
257. Cross, A. J., Freedman, N. D., Ren, J., Ward, M. H. et al., Meat consumption and risk of esophageal and gastric cancer in a large prospective study. Am. J. Gastroenterol. 2011, 106, 432-442.
258. Chan, D. S. M., Lau, R., Aune, D., Vieira, R. et al., Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS One 2011, 6, e20456.
259. Sinha, R., Cross, A. J., Graubard, B. I., Leitzmann, M. F. et al., Meat intake and mortality: a prospective study of over half a million people. Arch. Int. Med. 2009, 169, 562-571.
260. Ward, M. H., Cantor, K. P., Riley, D., Merkle, S. et al., Nitrate in public water supplies and risk of bladder cancer. Epidemiology 2003, 14, 183-190.
261. Ward, M. H., Cerhan, J. R., Colt, J. S., Hartge, P., Risk of non-Hodgkin lymphoma and nitrate and nitrite from drinking water and diet. Epidemiology 2006, 17, 375-382.
262. Kilfoy, B. A., Zhang, Y., Park, Y., Holford, T. R. et al., Dietary nitrate and nitrite and the risk of thyroid cancer in the NIH-AARP Diet and Health Study. Int. J. Cancer 2011, 129, 160-172.
263. Cross, A. J., Ferrucci, L. M., Risch, A., Graubard, B. I. et al., A large prospective study of meat consumption and colorectal cancer risk: an investigation of potential mechanisms underlying this association. Cancer Res. 2010, 70, 2406-2414.
264. Dubrow, R., Darefsky, A. S., Park, Y., Mayne, S. T. et al., Dietary components related to N-nitroso compound formation: a prospective study of adult glioma. Cancer Epidemiol. Biomarkers Prev. 2010, 19, 1709-1722.
265. Aschebrook-Kilfoy, B., Ward, M. H., Gierach, G. L., Schatzkin, A. et al., Epithelial ovarian cancer and exposure to dietary nitrate and nitrite in the NIH-AARP Diet and Health Study. Eur. J. Cancer Prev. 2012, 21, 65-72.
266. Dellavalle, C. T., Daniel, C. R., Aschebrook-Kilfoy, B., Hollenbeck, A. R. et al., Dietary intake of nitrate and nitrite and risk of renal cell carcinoma in the NIH-AARP Diet and Health Study. Br. J. Cancer 2013, 108, 205-212.
267. Ferrucci, L. M., Sinha, R., Ward, M. H., Graubard, B. I. et al., Meat and components of meat and the risk of bladder cancer in the NIH-AARP Diet and Health Study. Cancer 2010, 116, 4345-4353.
268. Aschebrook-Kilfoy, B., Cross, A. J., Stolzenberg-Solomon, R. Z., Schatzkin, A. et al., Pancreatic cancer and exposure to dietary nitrate and nitrite in the NIH-AARP Diet and Health Study. Am. J. Epidemiol. 2011, 174, 305-315.
269. Daniel, C. R., Cross, A. J., Graubard, B. I., Park, Y. et al., Large prospective investigation of meat intake, related mutagens, and risk of renal cell carcinoma. Am. J. Clin. Nutr. 2012, 95, 155-162.
270. Huncharek, M., Kupelnick, B., Wheeler, L., Dietary cured meat and the risk of adult glioma: a meta-analysis of nine observational studies. J. Environ. Pathol. Toxicol. Oncol. 2003, 22, 129-137.
271. Michaud, D. S., Holick, C. N., Batchelor, T. T., Giovannucci, E. et al., Prospective study of meat intake and dietary nitrates, nitrites, and nitrosamines and risk of adult glioma. Am. J. Clin. Nutr. 2009, 90, 570-577.
272. Terry, M. B., Howe, G., Pogoda, J. M., Zhang, F. F. et al., An international case-control study of adult diet and brain tumor risk: a histology-specific analysis by food group. Ann. Epidemiol. 2009, 19, 161-171.
273. Loh, Y. H., Jakszyn, P., Luben, R. N., Mulligan, A. A. et al., N-nitroso compounds and cancer incidence: the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk Study. Am. J. Clin. Nutr. 2011, 93, 1053-1061.
274. Jakszyn, P., Bingham, S., Pera, G., Agudo, A. et al., Endogenous versus exogenous exposure to N-nitroso compounds and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study. Carcinogenesis 2006, 27, 1497-1501.